Please login to the form below

Not currently logged in
Email:
Password:

personalised medicine

This page shows the latest personalised medicine news and features for those working in and with pharma, biotech and healthcare.

Revolutionising how healthcare is delivered

Revolutionising how healthcare is delivered

Imagine if a shipment holding medicine that was personalised for the DNA of a cancer patient was spoiled or stolen. ... The complete visibility of healthcare shipments is needed as medicines become more personalised and more potent.

Latest news

  • NICE: We're the institute of 'yes' NICE: We're the institute of 'yes'

    Personalised medicine challenges. The QuintilesIMS meeting also discussed the scale of the health technology assessment challenge presented by personalised medicines, particularly in oncology. ... At the moment personalised medicine scares us, because

  • NICE backs Europe's first stem cell therapy NICE backs Europe's first stem cell therapy

    We are delighted that NICE has recommended that eligible patients have access to this personalised and regenerative medicine for a rare and seriously debilitating orphan condition," commented Chiesi's UK managing

  • EMA starts firming up its stance on personalised medicines EMA starts firming up its stance on personalised medicines

    New draft European guidelines on personalised medicines and companion diagnostics are expected to be released by December 2018. ... a personalised medicine.

  • Keytruda is first FDA-approved drug for molecular indication Keytruda is first FDA-approved drug for molecular indication

    Keytruda is first FDA-approved drug for molecular indication. Indicates a significant development in the shift towards personalised medicine. ... month, although he noted that the development was very significant in the context of the shift towards

  • EMA develops framework for academia collaborations EMA develops framework for academia collaborations

    The agency has also created a new section on its website to provide information for academia, including details of its work in personalised medicine, big data, adaptive pathways and patient registries.

More from news
Approximately 8 fully matching, plus 117 partially matching documents found.

Latest Intelligence

  • The challenges of making genomics a reality for patients The challenges of making genomics a reality for patients

    It ushered in a new era of what we now call personalised medicine. ... To put this in context, developing the first cystic fibrosis medicine that treats the underlying cause took.

  • Bridging pharma’s digital gap Bridging pharma’s digital gap

    The rise of sophisticated technology assisting in the creation of personalised medicine would be naming just one example that came as a great leap for both the industry and mainstream medicine. ... The desire for customers to have personalised content

  • The challenges of making genomics a reality for patients today, not tomorrow The challenges of making genomics a reality for patients today, not tomorrow

    It ushered in a new era of what we now call personalised medicine. ... Fast-forward 18 years and more than ever we see the potential of how precision medicine could transform care.

  • The real-world data conundrum The real-world data conundrum

    No matter how we look at it, our approaches towards medicine are changing. ... At the core of this spectrum are patients. As the understanding of stratified, personalised medicine has grown over the last decade, a promise has emerged that there will be a

  • Patently unclear? Patently unclear?

    Another example of such obstacles is the question of whether you can get patent protection for methods of diagnosing disease and for personalised medicine. ... It appears that the situation is still evolving and that for the time being getting patent

More from intelligence
Approximately 4 fully matching, plus 23 partially matching documents found.

Latest appointments

  • Stephen Eck joins Aravive Biologics Stephen Eck joins Aravive Biologics

    chairman of the board of directors of the Personalised Medicine Coalition.

  • FlowMetric Diagnostics names president FlowMetric Diagnostics names president

    It is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalised medicine and better meet the needs of physicians, healthcare workers and

  • GlobalData makes Americas appointment GlobalData makes Americas appointment

    Dr Bonnie Bain, global head of healthcare at GlobalData, adds: “ Sean is widely recognised as an expert and thought leader in personalised and translational medicine, and it's great to welcome

  • Roche appoints new oncology research head Roche appoints new oncology research head

    Personalised cancer has been his forte, however, and he has served as director of personalised cancer medicine at Vanderbilt. ... I was particularly attracted to Roche as one of the pioneers and front-runners in personalised medicine, as the world's top

  • Former FDA adviser joins Precision for Medicine Former FDA adviser joins Precision for Medicine

    Former FDA adviser joins Precision for Medicine. Vicki Seyfert-Margolis appointed chief of science and strategy at life science research company. ... During this time, she led the FDA's regulatory science and personalised medicine initiative, as well as

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics